Anjarium Biosciences

Anjarium Biosciences Presents Data Demonstrating Novel Synthetic DNA Applications for Cell and Gene Therapies at 27th Annual ASGCT Meeting

Anjarium Biosciences appoints Chief Technology Officer

Anjarium Biosciences appoints Chairperson and Non-executive Director

Anjarium Biosciences appoints experienced industry executives

Anjarium Biosciences appoints Chief Executive Officer

Anjarium Biosciences Raises CHF 55.5M ($61M) Series A Financing